VeriMomcannabis sativa flower extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
Pregnancy-safe products containing cannabis sativa flower extract
Related ingredients
Frequently asked questions
- cannabis sativa flower extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
- cannabis sativa flower extract est-il sûr pendant l'allaitement ?
- No authoritative classification or safety assessment (CIR/SCCS/ECHA harmonised) identifying breastfeeding-specific hazard for topical 'cannabis sativa flower extract'. Transfer to breast milk would require systemic absorption of cannabinoids; topical cosmetic use is expected to produce negligible maternal systemic levels. Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (systemic cannabinoid transfer studies noted but not applicable to low topical exposures).
- cannabis sativa flower extract est-il sûr pour la peau de bébé ?
- No evidence of intrinsic reproductive or developmental hazard of the botanical extract for infant topical use in authoritative sources. However, infant skin has higher per‑kg absorption and an immature barrier; if the extract contains measurable cannabinoids or other small lipophilic constituents there is potential for greater dermal uptake in 0–3 yr olds than adults. Therefore exposure score is increased by +1 (from adult negligible to low but measurable). Sources: CosIng (ingredient present in cosmetic inventories), general dermal absorption principles and PubMed literature on cannabinoid absorption (systemic effects relate to systemic exposure, not topical cosmetic use).
- Comment VeriMom évalue-t-il cannabis sativa flower extract ?
- VeriMom évalue cannabis sativa flower extract à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à cannabis sativa flower extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à cannabis sativa flower extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.